KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-19 Cr | ₹11 Cr | ₹0.69 Cr | ₹1.53 Cr | ₹4.93 Cr |
What is the latest Net Cash Inflow / Outflow ratio of KOPRAN ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-19 Cr |
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹0.69 Cr |
| Mar2023 | ₹1.53 Cr |
| Mar2022 | ₹4.93 Cr |
How is Net Cash Inflow / Outflow of KOPRAN Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-19 Cr | Negative | |
| Mar2025 | ₹11 Cr | 1,537.70 | |
| Mar2024 | ₹0.69 Cr | -54.52 | |
| Mar2023 | ₹1.53 Cr | -69.02 | |
| Mar2022 | ₹4.93 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹1,160.2 Cr | 9.7% | 33.6% | 41.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 9.7% |
33.6% |
41.7% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses